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Select: Lipids Out LoudIf RNA ruled the last decade and DNA dominated the previous one, could the next decade be the one for
lipids? The ultimate energy storage units, lipids are well known for encasing the cell in a watertight
membrane, but lipids are oh-so much more. In particular, lipids are emerging as key signaling molecules
in eukaryotes, transmittingmessages both within and between cells. In this Select, we explore recent studies
highlighting the diverse physiological roles of these ‘‘lipid messengers’’—from modulating pain perception
and bone formation to reining in renegade inflammatory responses.Phosphatidic acid (PA) serves as a pH
sensor in yeast, linking glucose avail-
ability to membrane biogenesis through
its interaction with the transcriptional
repressor Opi1. Image courtesy of
C. Loewen.Lipid pH Meter Senses Nutrient Status
The diversity of lipids in eukaryotic cells—estimated to be > 1000—is daunting. But, in
terms of signaling roles, phosphatidic acid is quickly rising to the top. Ubiquitous in
cellular membranes, phosphatidic acid is known to recruit cytosolic proteins to their
appropriate location at membrane surfaces. Now, Young et al. demonstrate that
phosphatidic acid also serves as a pH sensor in Saccharomyces cerevisiae, coupling
the nutrient status of the cell to membrane biogenesis.
In yeast, the transcriptional repressor Opi1 regulates membrane production by
blocking transcription of genes required for the synthesis of lipid precursors. During
periods of growth, Opi1 is retained outside of the nucleus by its interaction with phos-
phatidic acids in the endoplasmic reticulum (ER) membrane. To identify new path-
ways that regulate Opi1’s localization, Young et al. screen a library of yeast mutants
for their ability to make lipid precursors. Surprisingly, many genes that govern intra-
cellular pH are also required for keeping Opi1 bound to the ER membrane. Indeed,
a fluorescent version of Opi1 demonstrates that, when the pH of the cell drops,
Opi1 dissociates from the phosphatidic acid and travels to the nucleus to repress lipid
synthesis genes.
How does phosphatidic acid sense pH, and what physiological role does it serve?Glucose starvation triggers a rapid drop in intracellular pH from 7 to6.0. The phosphate group of phosphatidic acid is unique
among phospholipids in that it is negatively charged at pH 7 but neutral at pH <6.6. Young and colleagues demonstrate that
neutralizing phosphatidic acid dramatically weakens its affinity for Opi1, leading to the release of the metabolic suppressor
when nutrients are low. Given the universality of pH regulation in the cell and the ubiquity of phosphatidic acid in cellular
membranes, the authors speculate that this type of pH biosensor is probably a common signaling mechanism for coupling
a physiological state to membrane biogenesis.
Young et al. (2010). Science 329, 1085–1088.Fatty acid amide hydrolase (FAAH)
degrades the endocannabinoid ananda-
mide; ‘‘ananda’’ is Sanskrit for ‘‘bliss.’’
Image courtesy of D. Piomelli.A New High for Pain Treatment
Whereas phosphatidic acid is a key signaling lipid inside of cells, many lipids can also
transmit information between cells. One potent class of these ‘‘lipid messengers’’ is
endocannabinoids, such anandamide. Neurons secrete anandamide, which then
blocks pain perception by activating cannabinoid receptors in both the central and
peripheral nervous systems. Now, Clapper et al. (2010) develop a small molecule
that boosts anandamide levels in the peripheral nervous system, but not in the brain
or spinal cord. Despite its restricted range of action, thismolecule exhibits surprisingly
powerful analgesic effects in mice models of acute and chronic pain, opening a new
avenue for treating pain without unwanted psychotropic effects.
Anandamide is degraded by amembrane protein called fatty acid amide hydrolase,
or FAAH. Current inhibitors of FAAH raise anandamide concentrations but are quite
hydrophobic and thus easily cross the blood-brain barrier. To create FAAH inhibitors
that act only in the periphery, Clapper et al. add hydrophilic groups at sites unlikely to
alter interactions with FAAH. One molecule, called URB937, increases anandamide
levels in peripheral tissues, but not in the forebrain or hypothalamus. Most impor-
tantly, administration of this compound near damaged tissue reduces pain responses
in mice with efficacies comparable to centrally acting FAAH inhibitors and a common
nonsteroidal anti-inflammatory compound. These results suggest that amplifying
endocannabinoid levels in the peripheral nervous system alters the processing of
pain signals in the spinal cord, highlighting the potency of these lipid-based neuromo-
dulators throughout the body.
Clapper et al. (2010). Nature Neuroscience 13, 1265–1270.Cell 143, December 10, 2010 ª2010 Elsevier Inc. 853
The lipid oleoyl serine increases bone
mass, which is measured by microcom-
puted tomography. Image courtesy of
I. Bab and R. Mechoulam.C’est Bone La Vie
Although endocannabinoids are well known for regulating pain perception and appe-
tite, cannabinoid receptors are present on almost every cell type in the human body,
including osteoclasts and osteoblasts in bones. Mammalian bones undergo
a constant remodeling process whereby osteoclasts break up the mineralized matrix
while osteoblasts replace it with new tissue. Endocannabinoids are known to regulate
this process, but the details are still unclear. Now, Smoum et al. identify an endocan-
nabinoid-related lipid called oleoyl serine, which tilts bone remodeling in favor of the
osteoblasts. Remarkably, treatment with this lipid rescues more than half of the bone
loss observed in a mice model of osteoporosis.
Smoum et al. first extract lipids from the femur and tibia of mice. They then use
a combination of mass spectrometry and chromatography to confirm the presence
of known lipids such as anandamide and uncover new ones such as oleoyl serine,
a lipid synthesized from a major ingredient in olive oil (i.e., oleic acid). Smoum et al.
find that oleoyl serine stimulates the growth of cultured osteoblasts at extremely
low concentrations (10 picomolar), making oleoyl serine the most potent of the
bone lipids in this in vitro cell proliferation assay. In addition, oleoyl serine limits the
life span of osteoclasts by triggering apoptosis. Despite the orthogonal effects ofoleoyl serine in osteoclasts and osteoblasts, this lipid signals through a Gi protein-coupled receptor and the Erk1/2 (extracel-
lular regulated kinases 1/2) kinase pathway in both cells.
Finally, Smoum and colleagues demonstrate that, unlike current treatments for osteoporosis, oleoyl serine displays
a double-pronged attack against bone loss in a mouse model for osteoporosis. It not only boosts the rate of bone formation,
but also slows down bone resorption, making oleoyl serine an attractive new lead for more potent therapeutics against this
widespread disease.
Smoum et al. (2010). Proceedings of the National Academy of Sciences 107, 17710–17715.Cyclooxygenase-2 (COX-2) converts do-
cosahexaenoic acid (DHA) from fish oil
into ‘‘electrophilic’’ fatty acids that acti-
vate and inhibit pro- and anti-inflamma-
tory processes, respectively. Image
courtesy of F. Schopfer.OMGega-3s! COX-2 Makes Anti-Inflammatories
Endocannabinoids and oleoyl serine are lipid messengers synthesized within cells,
but dietary fats can also serve signaling roles. For example, clinical studies suggest
that omega-3 fatty acids in fish oil, such as docosahexaenoic acid (DHA), help to
prevent diseases associated with chronic inflammation, but how these lipids mediate
an anti-inflammatory effect is still largely unknown. Now, Groeger et al. demonstrate
that, during an inflammatory response, human macrophages convert DHA into
oxidized fatty acids that directly activate anti-inflammatory transcription factors,
such as the nuclear receptor peroxisome proliferator-activated g (PPARg). Moreover,
these anti-inflammatory lipids are generated by cyclooxygenase-2 (COX-2), the
enzyme best known as the target of ibuprofen and for catalyzing the synthesis of
pro-inflammatory lipids prostaglandins.
Groeger et al. first develop a clever mass spectrometry approach that detects
reactive lipids even at extremely low concentrations. Using this technique, they
then identify derivatives of DHA generated in cultured monocytes and macrophages
after these cells are activated by various immune triggers, including interferon g and
lipopolysaccharide. Next, the authors show that the production of these DHA metab-
olites requires COX-2, and purified COX-2 can synthesize these lipids in vitro. Finally,
Groeger and colleagues demonstrate that two of the DHA metabolites suppress the
expression of pro-inflammatory cytokines (e.g., IL-6 and IL-10) in a dose-dependent
manner and boost nuclear localization of Nrf2, the master transcription factor for the
antioxidant response in immune cells.
Interestingly, COX-2 starts to generate these anti-inflammatory lipids 8–10 hours after the initiation of an immune
response. Together with the clinical studies on fish oil supplementation, these results suggest that the production of oxidized
DHAderivatives byCOX-2maybe a keymechanism for preventing an acute inflammatory response from turning into a chronic
and damaging one.
Groeger et al. (2010). Nature Chemical Biology 6, 433–441.
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